Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2993 of 6351
-
Melanoma patients monitored for Long-Term effects after experimental drug combo
Knowledge-focused By invitation onlyThis study is researching the long-term effects of a combination of experimental drugs called fianlimab and cemiplimab. The study is being conducted in patients with advanced skin cancer (melanoma) who had previously been treated with fianlimab and cemiplimab in the study called …
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Can a smart patch beat fingersticks for blood sugar control?
Disease control Recruiting nowThis is an open label, two-arm, randomized multi-center clinical device study in adult subjects with Type 1 diabetes (T1D) or insulin-dependent Type 2 diabetes (T2D) on a multiple daily injection (MDI) regime. The goal of the study is to investigate the impact of the Accu-Chek S…
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug trial targets liver scarring in MASH patients
Disease control OngoingThe purpose of this study is to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and activity of RO7790121 in participants with advanced metabolic dysfunction-associated steatohepatitis (MASH) fibrosis.
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Liver cancer drugs under Real-World watch in korea
Disease control Recruiting nowBased on the re-review of new drugs article, Korean pharmaceutical act, the objectives of this study are to assess safety and effectiveness of the study drugs(Imjudo \& Imfinzi) in a real world setting in patients who treated according to the approved indications in Korea.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New allergy pill shows promise in ragweed season trial
Symptom relief CompletedThis study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary clinical activity of BLU-808 in participants with ragweed (Ambrosia artemisiifolia)-induced allergic rhinoconjunctivitis (ARC). Participants will undergo eligibility a…
Phase 2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can exercise and diet tame the pain of fibromyalgia and IBS?
Symptom relief Recruiting nowFibromyalgia (FM) is a chronic disorder marked by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive difficulties. Patients often experience hyperalgesia, allodynia, and muscle weakness. Central sensitization plays a key role, making the nervous system mo…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New brain artery device under Real-World watch
Disease control Recruiting nowA multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Sponsor: Vesalio • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could skipping sedation help ventilated COPD patients recover faster?
Symptom relief CompletedThis study aims to evaluate the safety and efficacy of no-sedation compared to daily interruption of sedation (DIS) in mechanically ventilated patients with chronic obstructive pulmonary disease (COPD). Mechanical ventilation is associated with discomfort, anxiety, and agitation,…
Phase 2 • Sponsor: Al-Azhar University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Experimental cocktail aims to shrink tough tumors
Disease control OngoingAn open-label, Phase I/Ib study investigating the safety and efficacy of tiragolumab + atezolizumab + RadScopal™ XRT in patients with metastatic solid malignancies.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Simple massage and relaxation may soothe dialysis cramps
Symptom relief CompletedMuscle cramps are a common and distressing issue among hemodialysis patients, significantly impacting their quality of life. Non-pharmacological approaches are increasingly being explored to alleviate these symptoms. Massage therapy and progressive muscle relaxation exercises are…
Sponsor: University of Yalova • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
AI vs dentist: which gives better oral hygiene tips for prediabetes?
Disease control Recruiting nowPrediabetes is an intermediate stage before the development of diabetes, characterized by elevated blood glucose levels but lower than the diagnostic criteria of diabetes and is associated with multiple long-term complications. This systemic disease is mutually linked to inflamma…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo aims to tame rare inflammatory disease
Disease control Recruiting nowIn patients with Rosai-Dorfman disease (RDD), a treatment regimen of lenalidomide combined with dexamethasone is planned to be used.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a common immune treatment help preemies breathe easier?
Disease control Recruiting nowIt is intended to examine the efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatabl…
Phase 2 • Sponsor: International Peace Maternity and Child Health Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Home trunk training may boost motor skills in children with cerebral palsy
Symptom relief CompletedThe goal of this feasibility study is to evaluate the adherence, parental experiences, and perceptions of a home-based Intensive Segmental Trunk Training (ISTT) program for children aged 4-12 with spastic diplegic cerebral palsy (CP) in Pakistan. The main questions it aims to ans…
Sponsor: Iqra Khan • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Smart brain zapper aims to lift depression
Symptom relief CompletedThe purpose of this research study is to study a closed-loop transcranial alternating current stimulation (tACS) device to evaluate feasibility of the product in a clinical trial and collect preliminary data on potential effects on symptoms of depression in people with major depr…
Sponsor: Pulvinar Neuro, LLC • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Video games and shake therapy: a new way to build muscle in DMD kids?
Symptom relief Completedwe measure balance and quadriceps strength in Duchenne muscular dystrophy children after applying virtual reality and whole body vibration
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New implant could replace eye drops after corneal surgery
Disease control By invitation onlyThis study aims to compare the use of Dextenza, an FDA-approved intracanilular drug-eluting insert that is designed to deliver a tapered dose of dexamethasone to the ocular surface for 30 days, to the standard of care, or the use of a month-long topical prednisolone acetate 1% (P…
Phase 1/2 • Sponsor: Maanasa Indaram, MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a shot of your own fat make rotator cuff surgery last longer?
Disease control Recruiting nowSpecific Aims : The aim of this prospective randomized controlled single-blind clinical trial was to evaluate the safety and efficacy of autologous microfragmented lipoaspirate tissue in arthroscopic rotator cuff repair. The primary goal of this study was to test the following …
Sponsor: University of Milan • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo targets mysterious cancers
Disease control OngoingThe goal of this clinical research study is to learn if the combination of atezolizumab and tiragolumab can help to control cancers of unknown primary. The safety and effects of this drug combination will also be studied
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Smart glove could bring arm rehab home for brain injury patients
Disease control Recruiting nowThe aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Glove by comparing the effects between a group using the home-based Neofect Smart Glove and a group performing conventional home…
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC